Molecular Imaging and Radionuclide Therapy Q3 Unclaimed
Galenos Publishing House
Turkey
Molecular Imaging and Radionuclide Therapy is a journal indexed in SJR in Radiology, Nuclear Medicine and Imaging with an H index of 13. It is an CC BY-NC-ND Journal with a Double blind peer review review system The scope of the journal is focused on radionuclide therapy, radionuclide imaging, perfusion imaging, scintigraphy, positron-emission tomography, molecular imaging. It has an SJR impact factor of 0,272 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,272.
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Categories:
Radiology, Nuclear Medicine and Imaging (Q3)
Price
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,272
SJR Impact factor13
H Index53
Total Docs (Last Year)110
Total Docs (3 years)696
Total Refs88
Total Cites (3 years)105
Citable Docs (3 years)0.8
Cites/Doc (2 years)13.13
Ref/DocOther journals with similar parameters
Clinical and Translational Imaging Q3
Topics in Magnetic Resonance Imaging Q3
Neuroradiology Journal Q3
Techniques in Vascular and Interventional Radiology Q3
International Journal of Molecular Imaging Q3
Compare this journals
Aims and Scope
Radionuclide therapy
Radionuclide imaging
Perfusion imaging
Scintigraphy
Positron-emission tomography
Molecular imaging
Comments